EUVIMEDAvasta EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Vitamin C Supplementation in Hospitalized Patients With Community-Acquired Pneumonia: Protocol for a Randomized Controlled Trial

Yogesh Sharma iD, Arduino A Mangoni iD, Richard Woodman iD, Huah Shin Ng iD, Manisha Arthur iD, Subodha Sumanadasa iD, Shailesh Bihari iD, Campbell Thompson iD

JMIR Research Protocols · 2026-04-29 · 15 · e91037

DOI: 10.2196/91037 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2026-04-29. Written by Yogesh Sharma and 7 co-authors. Institution: College of Medicine & Public Health, Flinders University, Adelaide, SA, Australia. Major MEDLINE topics: Community-Acquired Pneumonia, Ascorbic Acid, Dietary Supplements. 25 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Background

Community-acquired pneumonia (CAP) remains a leading cause of hospitalization, morbidity, and mortality worldwide, particularly among older adults with multimorbidity and frailty. Despite advances in antimicrobial therapy, clinical outcomes have improved little, highlighting the need for safe, inexpensive adjunctive treatments. Vitamin C plays a critical role in immune function, redox homeostasis, and endothelial integrity, all disrupted during acute infection. Hypovitaminosis C is common in hospitalized patients with CAP and has been associated with increased disease severity, longer length of stay (LOS), and worse outcomes. However, prior randomized trials of vitamin C have produced inconsistent results, often focusing on critically ill patients with sepsis, using short treatment durations, and discontinuing therapy abruptly.

Objective

The Vitamin C in Community-Acquired Pneumonia (VitCAP) trial aims to evaluate whether high-dose oral vitamin C administered over an extended period improves clinical recovery and patient-centered outcomes in adults hospitalized with CAP.

Methods

VitCAP is a single-center, double-blind, placebo-controlled, parallel-group randomized clinical trial conducted at a tertiary hospital in Australia. Adults aged 18 years and older hospitalized with CAP will be randomized within 48 hours of admission in a 1:1 ratio to receive either oral sodium ascorbate (1 g 3 times daily for 7 days, followed by 500 mg twice daily for 30 days) or a matching placebo in addition to standard care. Randomization will be computer generated with allocation concealment via a centralized pharmacy service, and all participants, clinicians, investigators, and outcome assessors will remain blinded. The primary outcome is time to clinical stabilization, defined using standard physiological criteria. Secondary outcomes include early clinical response, symptom burden at 30 days, intensive care unit admission, need for ventilatory or vasopressor support, LOS, all-cause mortality at 30 days and 6 months, hospital readmission, health-related quality of life, and changes in inflammatory biomarkers (C-reactive protein and procalcitonin). Analyses will follow the intention-to-treat principle. The primary outcome will be analyzed using Cox proportional hazard regression adjusted for prespecified covariates, with sensitivity analyses including restricted mean survival time.

Results

The VitCAP trial received ethics approval from the Southern Adelaide Local Health Network Human Research Ethics Committee in 2025 and funding in September 2025. Recruitment is expected to commence in 2026 and continue for 18 to 24 months. A total of 124 participants will be enrolled to provide 80% power to detect a clinically meaningful difference in time to clinical stabilization while allowing for attrition. Data analysis will follow completion of follow-up, with primary results anticipated in 2028.

Conclusions

The VitCAP trial is designed to address important evidence gaps by evaluating sustained oral vitamin C supplementation in hospitalized patients with CAP using clinically meaningful patient-centered outcomes. If effective, vitamin C could represent a safe, low-cost, and scalable adjunct to standard CAP management. Trial Registration Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12625001361493; https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12625001361493 International Registered Report Identifier (IRRID) PRR1-10.2196/91037

Subjects

MeSH terms (MEDLINE)

Community-Acquired PneumoniaAscorbic AcidDietary SupplementsHumansDouble-Blind MethodHospitalizationRandomized Controlled Trials as TopicAustraliaMaleAgedFemaleAdultCommunity-Acquired InfectionsMiddle Aged

Author keywords

adjunctive therapyclinical stabilizationcommunity-acquired pneumoniarandomized controlled trialvitamin C supplementation

Substances

Ascorbic Acid

Authors and institutions

  • College of Medicine & Public Health, Flinders University, Adelaide, SA, Australia.
  • Department of Acute and General Medicine, Flinders Medical Centre, Adelaide, SA, Australia.
  • Intensive and Critical Care Unit, Flinders Medical Centre, Adelaide, SA, Australia.
  • Discipline of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.

ORCID profiles: Yogesh Sharma, Arduino A Mangoni, Richard Woodman, Huah Shin Ng, Manisha Arthur, Subodha Sumanadasa, Shailesh Bihari, Campbell Thompson

Cite

APA

Sharma, Y., Mangoni, A. A., Woodman, R., Ng, H. S., Arthur, M., Sumanadasa, S., Bihari, S., & Thompson, C. (2026). Vitamin C Supplementation in Hospitalized Patients With Community-Acquired Pneumonia: Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 15, e91037. https://doi.org/10.2196/91037

Vancouver

Sharma Y, Mangoni AA, Woodman R, Ng HS, Arthur M, Sumanadasa S, et al. Vitamin C Supplementation in Hospitalized Patients With Community-Acquired Pneumonia: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e91037. doi:10.2196/91037

BibTeX
@article{Sharma2026,
  author = {Sharma, Yogesh and Mangoni, Arduino A and Woodman, Richard and Ng, Huah Shin and Arthur, Manisha and Sumanadasa, Subodha and Bihari, Shailesh and Thompson, Campbell},
  title = {Vitamin C Supplementation in Hospitalized Patients With Community-Acquired Pneumonia: Protocol for a Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e91037},
  doi = {10.2196/91037}
}
Start for free →